Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: Diagnosis of cirrhosis and complications

Journal of Clinical Gastroenterology

Volumn 41, Issue 1, 2007, Pages 103-110

  Denzer, Ulrike ^a,b   Arnoldy, Andrea ^a   Kanzler, Stefan ^a   Galle, Peter R ^a   Dienes, Hans P ^c   Lohse, Ansgar W ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Complications of liver biopsy; Liver biopsy; Liver cirrhosis; Minilaparoscopy; Percutaneous liver biopsy

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; DATA ANALYSIS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LAPAROSCOPY; LIVER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

ADULT; BIOPSY; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LAPAROSCOPY; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 33845965384     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225612.86846.82     Document Type: Article

References (39)

1. Bravo A, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
2. Nord HJ. Biopsy diagnosis of cirrhosis: blind percutaneous versus direct vision techniques - a review. Gastointest Endosc. 1992;28:102-104.
3. Poniachik J, Bernstein DE, Reddy R, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastroint Endosc. 1996;43:568-571.
4. Helmreich-Becker I, Meyer zum Büschenfelde KH, Lohse AW. Safety and feasibility of a new minimally invasive diagnostic laparoscopy technique. Endoscopy. 1998;30:756-762.
5. Kalk H. Erfahrungen mit der Laparoskopie. Z Klin Med. 1929;111:303.
6. Henning H, Look D. Laparoskopie, Atlas und Lehrbuch. New York: Thieme, Stuttgard; 1985.
7. Piccinino F, Sagnelli E, Pasquale G, et al. Compications following percutanous liver biopsy. J Hepatol. 1986;2:164-173.
8. McGill DB, Rakela J, Zinsmeister AR, et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990;99:1396-1400.
9. Menghini G. One-second needle biopsy of the liver. Gastroenterology. 1958;35:190.
10. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
11. Jeffers LJ, Findor A, Thung SN, et al. Minimizing sampling error with laparoscopic guided liver biopsy of right and left lobes. Gastrointest Endosc. 1991;37:A266.
12. Helmreich-Becker I, Hensel A, Denzer U, et al. Minilaparoscopy in the diagnosis of cirrhosis - superioritiy in child. A patient's and macronodular disease. Endoscopy. 2003;35:55-60.
13. Pagliaro L, Rinaldi F, Craxi A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. Dig Dis Sci. 1983;28:39-43.
14. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614-2618.
15. Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39:239-244.
16. Poynard T, Imbert-Bismut F, Ratziu V, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepatitis. 2002;9:128-133.
17. Myers RP, Tainturier MH, Ratziu V, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol. 2003;39:222-230.
18. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343-350.
19. Rossi E, Adams L, Prins A, et al. Validation of the fibrotest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem. 2003;49:450-454.
20. Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376-1382.
21. Yano M, Kumkada H, Kage M, et al. The long term pathological evolution of chronic hepatitis C. Hepatology. 1996;23:1334-1340.
22. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349:825-832.
23. Alberti A, Noventa F, Benvegnu L, et al. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med. 2002;137:961-964.
24. Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon Alpha 2 a in patients with chronic hepatitis C. N Engl J Med. 2000;343:1666-1672.
25. Manns MP, McHutchison JG, Gordon SC, et al. PEG-Interferon alpha 2b in combination with ribavirin compared to interferon alpha 2b plus ribavirin for initial treatment of chronic hepatitis C. Lancet. 2001;358:958-965.
26. Heathcote EJ, Shiffman ML, Cooksley GE, et al. Peginterferon alfa 2 a in patietns with chronic hepatitis C and cirrhosis. N Engl J Med. 2000;343:1673-1680.
27. Fattovich G, Guistina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463-472.
28. Zaman SN, Johnson PJ, Williams R. Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high incidence and low-incidence areas. Cancer. 1990;65:1607-1610.
29. Yuen MF, Cheng CC, Lauder IJ, et al. Early detection of hepatocellullar carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31:330-335.
30. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellullar carcinoma in Alaska natives infected with chronic hepatitis B: a 16 year population based study. Hepatology. 2000;32:842-846.
31. van Thiel DH, Gavaler JS, Wright H, et al. Liver biopsy. Its safety and complications as seen at a transplant center. Transplantation. 1993;55:1087-1090.
32. Brühl W. Zwischenfälle und Komplikationen bei der Laparoskopie und gezielten Leberpunktion. Deutsch Med Wochenschrift. 1966;91:2297-2200.
33. Nord HJ. Complicationes of laparoscopy. Endoscopy. 1992;24:693-700.
34. Adamek HE, Maier M, Benz C, et al. Schwerwiegende Komplikationen der diagnostischen Laparoskopie. Neunjährige Erfahrung bei 747 Untersuchungen. Med Klinik. 1996;91:694-697.
35. Vargas C, Jeffers LJ, Bernstein D, et al. Diagnostic laparoscopy: a 5 year experience in a hepatology training program. Am J Gastroenterol. 1995;90:1258.
36. Perrault J, Mc Gill DB, Ott BJ, et al. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology. 1978;74:103-106.
37. Cadranel JF, Rufat P, Degos F. Practices od liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000;32:477-481.
38. Lazzaroni M, Porro GB. Preparation, premedication and surveillance. Endoscopy. 2005;37:101-109.
39. Glaser J, Mann O, Soegmüller M, et al. Prospective study of the incidence of ultrasound detected hepatic hematomas due to percutaneous Menghini needle liver biopsy and laparoscopy guided Silverman needle biopsy. Ital J Gastroenterol. 1994;26:338-341.